Please login to the form below

Not currently logged in
Email:
Password:

dementia

This page shows the latest dementia news and features for those working in and with pharma, biotech and healthcare.

Researchers reverse Alzheimer’s memory loss in mice

Researchers reverse Alzheimer’s memory loss in mice

This funding acknowledges the decades of failure in Alzheimer’s and dementia research, which has been largely based on targeting beta amyloid and tau – approaches which have so far not yielded

Latest news

  • NHS facing early exodus of skilled consultants NHS facing early exodus of skilled consultants

    Proposals to improve access to personalised care for early stage cancer sufferers, prevent 150, 000 heart attacks, stroke and dementia cases, and provide a 24/7 community-based mental health crisis

  • Axovant drops last ‘legacy’ drug to focus on gene therapies Axovant drops last ‘legacy’ drug to focus on gene therapies

    drug intended for use in dementia failed a mid-stage trial. ... Nelotanserin was being tested as a treatment for REM sleep behaviour disorder in patients with Lewy body dementia, but wasn’t able to reduce sleep disturbances compared to placebo.

  • Theranexus takes Alzheimer’s drug combo into clinic Theranexus takes Alzheimer’s drug combo into clinic

    Lyon-based Theranexus is pairing it with mefloquine, an antimalarial compound first introduced in the 1970s that it thinks has the potential to be re-purposed as a dementia treatment. ... While the ultimate aim of AD therapy is to develop treatments that

  • Tox trouble stalls Sosei/Allergan Alzheimer’s drug Tox trouble stalls Sosei/Allergan Alzheimer’s drug

    Surprise findings from primate studies. Sosei and Allergan have been forced to call a halt to testing of a drug for Alzheimer’s disease and other forms of dementia after cancer ... The upshot however is that a broader phase 2 programme for the drug in

  • Social care crisis looms as demand to double by 2035 Social care crisis looms as demand to double by 2035

    People with dementia and at least two other major health conditions, such as obesity or diabetes, will double over the next 20 years, likely to mean that an extra 500, 000

More from news
Approximately 30 fully matching, plus 166 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics